Abigail Bomba and Philip Richter's representation of Goldman Sachs, financial advisor to ViroPharma in its US$4.2 billion acquisition by Shire, reported by The Am Law Daily and <em>New York Law Journal</em>

Abigail Bomba and Philip Richter's representation of Goldman Sachs, financial advisor to ViroPharma in its US$4.2 billion acquisition by Shire, reported by The Am Law Daily and New York Law Journal

The Am Law Daily and New York Law Journal reported corporate partners Abigail Bomba and Philip Richter's representation of Goldman Sachs, financial advisor to ViroPharma Incorporated, in ViroPharma's US$4.2 billion acquisition by Shire.

news-detail.inc